No Data
Human Metabolome Technologies: Supplementary explanation of financial results for the 1st quarter of the fiscal year ending 2025/6
Human Metabolome Technologies: Summary of Financial Results for the 1st Quarter Ending June 2025 [Japanese GAAP] (Consolidated)
Human Metabolome Technologies: Extraordinary Report
Human Metabolome Technologies: Financial Report - Term 21 (2023/07/01 - 2024/06/30)
Moai, WASH House, and other [emerging market press releases]
<3692> FFRIsigns a business outsourcing contract with Cyber Research Consortium, which is engaged in technical research and development, investigation, analysis, and planning regarding cybersecurity.<4772>Stream Media resumes its shareholder benefit program.<4881>Fan Pep's 11th subscription rights (with exercise price adjustment clause) will be heavily exercised, and the number of shares to be issued from the 6th is 0.65 million shares of 5,000 each.<5031>Moi upward revision, this period's operating profit outlook is 0.165 billion yen←0.072 billion yen<6090>HMT focuses on natto bacteria.
Human Metabolome Technologies: June 2024 fiscal year-end financial results presentation materials.
No Data
No Data